B2M and pulmonary fibrosis: To rule out the effect of other diseases, such as lung cancer, aging, or obesity, we used a COPD rat model to validate our data indicating that increased β2M levels induce alveolar epithelial-mesenchymal transition (EMT) and pulmonary fibrosis in COPD.